ElizabethMittendorfMD

General Surgery • Boston, MA

Breast, Surgical Oncology (Other than Breast)

Physician

Join to view full profile

Dr. Mittendorf is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mittendorf's full profile

Already have an account?

Office
450 Brookline Avenue
Boston, MA 02215
Phone+1 617-582-9277

Education & Training

University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2005 - 2008
Case Western Reserve University School of MedicineClass of 1996

Certifications & Licensure

MA State Medical License 2017 - 2027
TX State Medical License 2005 - 2019
OH State Medical License 1997 - 2008
American Board of Surgery Surgery

Clinical Trials

Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA) Start of enrollment: 2020 Jul 02
ACTIVE_NOT_RECRUITING
PHASE2

Publications & Presentations

PubMed

ASO Visual Abstract: Risk of Surgical Overtreatment in cN1 Breast Cancer Patients Who Become ypN0 After Neoadjuvant Chemotherapy: SLNB Versus TAD.
Alison Laws, Saskia Leonard, Julie Vincuilla, Tonia Parker, Olga Kantor
Annals of Surgical Oncology. 2025-04-01
1 citations
Risk of Surgical Overtreatment in cN1 Breast Cancer Patients who Become ypN0 After Neoadjuvant Chemotherapy: SLNB Versus TAD.
Alison Laws, Saskia Leonard, Julie Vincuilla, Tonia Parker, Olga Kantor
Annals of Surgical Oncology. 2025-03-01
Phase I study of ribociclib (CDK4/6 inhibitor) with spartalizumab (PD-1 inhibitor) with and without fulvestrant in metastatic hormone receptor-positive breast cancer o...
Ana C Garrido-Castro, Noah Graham, Lestat R Ali, Christina Herold, Jennifer Desrosiers
Journal for Immunotherapy of Cancer. 2025-02-25

Press Mentions

22 Health Care Predictions for 2025 from Medical ResearchersDecember 31st, 2024
Omitting Axillary Lymph Node Dissection in Early Breast CancerDecember 23rd, 2024
ASCO Elects Dana-Farber/Brigham and Women's Elizabeth a. Mittendorf, MD, PhD, as 2026-2027 PresidentDecember 18th, 2024
Join now to see all